Related Experiment Video
Updated: Aug 19, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Antisense inhibition of osteogenic protein 1 disturbs human articular cartilage integrity
Stephan Söder1, Arnavaz Hakimiyan, David C Rueger
1Rush University Medical Center, Chicago, Illinois 60612, USA.
Objective:
To delineate the role of endogenous osteogenic protein 1 (OP-1) in human articular cartilage homeostasis via the inhibition of OP-1 gene expression by antisense oligonucleotides.
Methods:
Human adult normal articular cartilage was obtained from the knee and ankle joints of 34 organ donors. Chondrocytes were cultured as tissue explants or isolated cells in alginate or high-density monolayers for 48 hours in the presence of OP-1 antisense or sense oligonucleotides. The effect of OP-1 antisense inhibition was evaluated by reverse transcription-polymerase chain reaction, (35)S incorporation, dimethylmethylene blue assay, histology with Safranin O staining, and immunohistochemistry with anti-proOP-1, anti-mature OP-1, and anti-aggrecan antibodies.
Results:
Antisense treatment inhibited OP-1 gene expression by a mean +/- SD of 34 +/- 12% (P < 0.01) in chondrocytes cultured in monolayers and by 77 +/- 27% (P < 0.03) in alginate beads. The inhibition of autocrine OP-1 caused a striking decrease in aggrecan gene expression, in total proteoglycan content accumulated in cartilage matrix, and in the ability of chondrocytes to newly synthesize proteoglycans. OP-1 antisense reduced aggrecan messenger RNA expression by 42 +/- 17% (P < 0.05) and proteoglycan synthesis by 48 +/- 23% (P < 0.01). Histology and immunohistochemistry revealed a dramatic decrease in Safranin O staining and reduced anti-aggrecan staining (primarily in the superficial and middle cartilage layers) with OP-1 antisense treatment.
Conclusion:
Our results suggest that OP-1 is an important endogenous cartilage factor that regulates matrix integrity and possibly needs to be induced or up-regulated to maintain normal cartilage homeostasis. These findings confirm our hypothesis that a lack of autocrine OP-1 may lead to an elevated susceptibility of chondrocytes to the catabolic processes, thus contributing/promoting cartilage degeneration.
Insights
Endogenous osteogenic protein 1 (OP-1) is crucial for maintaining human articular cartilage health. Inhibiting OP-1 gene expression significantly reduces proteoglycan synthesis and matrix integrity, suggesting its role in preventing cartilage degeneration.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- Articular cartilage homeostasis is vital for joint function.
- Endogenous osteogenic protein 1 (OP-1) is implicated in cartilage biology.
- Understanding OP-1's role is key to addressing cartilage degeneration.
Purpose of the Study:
- To investigate the role of endogenous osteogenic protein 1 (OP-1) in human articular cartilage homeostasis.
- To inhibit OP-1 gene expression using antisense oligonucleotides to assess its effects.
- To delineate the impact of OP-1 on chondrocyte function and matrix integrity.
Main Methods:
- Human adult articular cartilage from 34 donors was used.
- Chondrocytes were cultured in explants, alginate, or monolayers with OP-1 antisense or sense oligonucleotides.
- Gene expression (RT-PCR), proteoglycan synthesis ((35)S incorporation, DMMB assay), and matrix integrity (histology, immunohistochemistry) were evaluated.
Main Results:
- Antisense treatment significantly inhibited OP-1 gene expression in chondrocytes (34-77%).
- OP-1 inhibition led to decreased aggrecan gene expression and proteoglycan synthesis (42-48%).
- Histology showed reduced Safranin O and aggrecan staining, indicating matrix degradation.
Conclusions:
- OP-1 is an essential endogenous factor regulating cartilage matrix integrity.
- Downregulation of OP-1 may increase chondrocyte susceptibility to catabolic processes.
- Maintaining or up-regulating OP-1 is potentially crucial for normal cartilage homeostasis and preventing degeneration.
